US20140018848A1 - Screw Catch Mechanism for PFO Occluder and Method of Use - Google Patents
Screw Catch Mechanism for PFO Occluder and Method of Use Download PDFInfo
- Publication number
- US20140018848A1 US20140018848A1 US14/026,896 US201314026896A US2014018848A1 US 20140018848 A1 US20140018848 A1 US 20140018848A1 US 201314026896 A US201314026896 A US 201314026896A US 2014018848 A1 US2014018848 A1 US 2014018848A1
- Authority
- US
- United States
- Prior art keywords
- occluder
- delivery
- catch member
- catch
- proximal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 21
- 230000007246 mechanism Effects 0.000 title abstract description 13
- 208000008883 Patent Foramen Ovale Diseases 0.000 abstract description 32
- 229920000642 polymer Polymers 0.000 abstract description 15
- 208000035478 Interatrial communication Diseases 0.000 abstract description 7
- 206010003664 atrial septal defect Diseases 0.000 abstract description 7
- 208000013914 atrial heart septal defect Diseases 0.000 abstract description 5
- 230000007556 vascular defect Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 description 15
- PPTYJKAXVCCBDU-UHFFFAOYSA-N Rohypnol Chemical compound N=1CC(=O)N(C)C2=CC=C([N+]([O-])=O)C=C2C=1C1=CC=CC=C1F PPTYJKAXVCCBDU-UHFFFAOYSA-N 0.000 description 11
- 230000004323 axial length Effects 0.000 description 10
- 238000001727 in vivo Methods 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 229910001000 nickel titanium Inorganic materials 0.000 description 6
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 6
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 6
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 6
- 230000001746 atrial effect Effects 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 229920000431 shape-memory polymer Polymers 0.000 description 5
- 210000005246 left atrium Anatomy 0.000 description 4
- 229920002791 poly-4-hydroxybutyrate Polymers 0.000 description 4
- 210000005245 right atrium Anatomy 0.000 description 4
- 239000012781 shape memory material Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 3
- 208000001910 Ventricular Heart Septal Defects Diseases 0.000 description 3
- 229910045601 alloy Inorganic materials 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000004491 foramen ovale Anatomy 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 201000003130 ventricular septal defect Diseases 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000002121 Paradoxical Embolism Diseases 0.000 description 2
- 229920000291 Poly(9,9-dioctylfluorene) Polymers 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000032109 Transient ischaemic attack Diseases 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 230000010100 anticoagulation Effects 0.000 description 2
- 210000003157 atrial septum Anatomy 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 201000010875 transient cerebral ischemia Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032382 Ischaemic stroke Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010027603 Migraine headaches Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000007213 cerebrovascular event Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 210000002458 fetal heart Anatomy 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000025339 heart septal defect Diseases 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000011295 pitch Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000004088 pulmonary circulation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 230000006441 vascular event Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00004—(bio)absorbable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00292—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery mounted on or guided by flexible, e.g. catheter-like, means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00592—Elastic or resilient implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00606—Implements H-shaped in cross-section, i.e. with occluders on both sides of the opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00619—Locking means for locking the implement in expanded state
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00623—Introducing or retrieving devices therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00681—Aspects not otherwise provided for
- A61B2017/00685—Archimedes screw
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00982—General structural features
- A61B2017/00986—Malecots, e.g. slotted tubes, of which the distal end is pulled to deflect side struts
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgical Instruments (AREA)
Abstract
Devices, delivery systems and delivery techniques for an occlusion device for the closure of physical anomalies, such as an atrial septal defect, a patent foramen ovale (PFO), and other septal and vascular defects are described. The devices, delivery systems and delivery techniques relate particularly to, but are not limited to, a patent foramen ovale (PFO) occluder made from a polymer tube, specifically, a petal-shaped occluder. In certain embodiments, the catch system includes a catch member with a screw catch mechanism for connecting to the occluder. A delivery system for use with the catch member includes a component for rotating the catch member relative to the occluder to engage the screw catch mechanism.
Description
- This application is a divisional application of U.S. application Ser. No. 11/729,045 filed Mar. 28, 2007, now pending; which claims the benefit under 35 USC §119(e) to U.S. Application Ser. No. 60/787,987 filed Mar. 31, 2006, now expired. The disclosure of each of the prior applications is considered part of and is incorporated by reference in the disclosure of this application.
- 1. Field of the Invention
- This invention relates generally to occlusion devices for the closure of physical anomalies, such as an atrial septal defect, a patent foramen ovale, and other septal and vascular defects. In particular, this invention relates to a catch mechanism to maintain the occluder in the deployed configuration. The invention also relates to delivery systems and mechanisms for such devices.
- 2. Background Information
- A patent foramen ovale (PFO), illustrated in
FIG. 1 , is a persistent, one-way, usually flap-like opening in the wall between theright atrium 11 andleft atrium 13 of theheart 10. Because left atrial (LA) pressure is normally higher than right atrial (RA) pressure, the flap usually stays closed. Under certain conditions, however, right atrial pressure can exceed left atrial pressure, creating the possibility that blood could pass from theright atrium 11 to theleft atrium 13 and blood clots could enter the systemic circulation. It is desirable that this circumstance be eliminated. - The foramen ovale serves a desired purpose when a fetus is gestating. Because blood is oxygenated through the umbilical cord, and not through the developing lungs, the circulatory system of the fetal heart allows the blood to flow through the foramen ovale as a physiologic conduit for right-to-left shunting. After birth, with the establishment of pulmonary circulation, the increased left atrial blood flow and pressure results in functional closure of the foramen ovale. This functional closure is subsequently followed by anatomical closure of the two overlapping layers of tissue:
septum primum 14 and septum secundum 16. However, a PFO has been shown to persist in a number of adults. - The presence of a PFO is generally considered to have no therapeutic consequence in otherwise healthy adults. Paradoxical embolism via a PFO is considered in the diagnosis for patients who have suffered a stroke or transient ischemic attack (TIA) in the presence of a PFO and without another identified cause of ischemic stroke. While there is currently no definitive proof of a cause-effect relationship, many studies have confirmed a strong association between the presence of a PFO and the risk for paradoxical embolism or stroke. In addition, there is significant evidence that patients with a PFO who have had a cerebral vascular event are at increased risk for future, recurrent cerebrovascular events. The presence of a PFO has also been linked to another condition, chronic migraine headaches. While researchers are still working on finding an explanation, PFO closure has been shown to eliminate or significantly reduce migraine headaches in many patients.
- In certain cases, such as when anticoagulation is contraindicated, surgery may be necessary or desirable to close a PFO. The surgery would typically include suturing a PFO closed by attaching septum secundum to septum primum. This sutured attachment can be accomplished using either an interrupted or a continuous stitch and is a common way a surgeon shuts a PFO under direct visualization.
- Umbrella devices and a variety of other similar mechanical closure devices, developed initially for percutaneous closure of atrial septal defects (ASDs), have been used in some instances to close PFOs. These devices potentially allow patients to avoid the side effects often associated with anticoagulation therapies and the risks of invasive surgery. However, umbrella devices and the like that are designed for ASDs are not optimally suited for use as PFO closure devices.
- Currently available septal closure devices present drawbacks, including technically complex implantation procedures. Additionally, there are significant complications due to thrombus, fractures of the components, conduction system disturbances, perforations of heart tissue, and residual leaks. Many devices have a high septal profile and include large masses of foreign material, which may lead to unfavorable body adaptation of a device. Given that ASD devices are designed to occlude holes, many lack anatomic conformability to the flap-like anatomy of PFOs. Thus, when inserting an ASD device to close a PFO, the narrow opening and the thin flap may form impediments to proper deployment. Even if an occlusive seal is formed, the device may be deployed in the heart on an angle, leaving some components insecurely seated against the septum and, thereby, risking thrombus formation due to hemodynamic disturbances. Finally, some septal closure devices are complex to manufacture, which may result in inconsistent product performance.
- Various devices and delivery systems have been developed to deliver occluders and other medical devices through body lumens. Some delivery systems of the prior art are used to deliver devices that readily expand to a delivered configuration when removed from the delivery system. Other occluders do not readily expand into a deployed configuration and techniques are used to change the configuration of the device into the deployed configuration. In the latter case, once an occluder is delivered to the desired delivery site and deployed, the occluder must have a catch system that keeps the device in the deployed configuration.
- The devices and techniques disclosed herein are designed to address these and other deficiencies of prior art septal closure devices and techniques for delivering and retrieving such devices.
- This description discloses a delivery system and technique(s) for delivering an implant into a desired location within the body and securing the device in the deployed configuration. The device(s) relate particularly to, but are not limited to, a septal occluder made from a polymer tube. The occluder includes a first side adapted to be disposed on one side of the septal tissue and a second side adapted to be disposed on the opposite side of the septal tissue. The first and second sides are adapted to occlude the aperture upon deployment of the device at its intended delivery location. The delivery technique, in addition to use with septal occluders, could be applied to other medical devices, such as other expandable devices constructed from an underlying tubular structure.
- In one embodiment, the present invention provides a catch system that maintains the configuration of an occluder once it has been deployed. In one aspect, the catch system includes a catch member having a threaded outside surface at the proximal end that can be threadably attached to the proximal side of the occluder. The distal end of the catch member includes a flange that can apply a proximal force on the distal end of the occluder. A delivery wire having a threaded outside surface at the distal end can be threadably attached to the proximal or distal end of the catch member, so that by pulling the delivery wire in the proximal direction, a proximal force is applied to the catch member and the distal end of the occluder. The delivery system also includes a delivery catheter that can be threadably attached to the proximal end of the occluder and can be used to maintain the position thereof. During deployment, the delivery wire can be used to pull the distal end of the occluder in the proximal direction, thereby converting the occluder into an expanded profile, deployed configuration. An inner catheter having a key that fits inside a slot at the proximal end of the catch member is provided to apply an axial twisting force upon the catch member. Using the inner catheter, the proximal ends of the catch member and the occluder can be threadably attached or detached.
- Before deployment, various components of the delivery system, catch system and the occluder in a reduced profile configuration can be connected and placed inside a delivery sheath. After moving the distal end of the delivery sheath past an aperture in the septum, the delivery sheath can be retracted. The delivery wire can then be used to convert the occluder to the expanded profile deployed configuration to occlude the aperture. The inner catheter can then be used to attach the proximal ends of the catch member and the occluder so that the occluder maintains the deployed configuration. After attachment, the delivery catheter can be detached from the occluder and removed. The occluder can later be retrieved if desired.
- In another aspect, the catch system includes a catch member having a threaded outside surface at the proximal end that can be threadably attached to the proximal side of the occluder. The distal end of the catch member includes a flange that can apply a proximal force on the distal end of the occluder. A delivery wire forms a loop around the distal end of the catch member. Two apertures may be used to loop the delivery wire around the distal end. The delivery wire could be a polymeric material or metallic material. In some embodiments it could be nitinol. In some embodiments, a delivery wire that can translate axial force in a pushing direction may be advantageous. The delivery system also includes a delivery catheter that can be threadably attached to the proximal end of the occluder and can be used to maintain the position thereof. During deployment, the delivery wire can be used to pull the distal end of the occluder in the proximal direction, thereby converting the occluder into an expanded profile, deployed configuration. An inner catheter having a slot at the distal end that fits a key at the proximal end of the catch member is provided to apply an axial twisting force upon the catch member. Using the inner catheter, the proximal ends of the catch member and the occluder can be threadably attached or detached.
- According to at least some embodiments, the occluder is formed from a tube. According to some embodiments, the tube includes a material selected from the group consisting of metals, shape memory materials, alloys, polymers, bioabsorbable polymers, and combinations thereof. In particular embodiments, the tube includes a shape memory polymer. In particular embodiments, the tube includes nitinol. In some embodiments, the tube is formed by rolling a flat piece of material into a tubular form. According to some embodiments, the occluder is formed by cutting the tube. In other embodiments, the occluder is formed from a plurality of filaments, aligned in a tubular arrangement and bonded at selected locations. The occluder is placed in its deployment configuration by reducing the axial length of the device.
- These and other aspects and embodiments of the invention are illustrated and described below.
-
FIG. 1 is a schematic representation of a human heart including various septal defects. -
FIG. 2 illustrates a deployed occluder according to an aspect of the invention. -
FIG. 3 illustrates introduction of the occluder in a human heart using a delivery system in accordance with an aspect of the invention. -
FIG. 4 illustrates a detail view of a delivery catheter in a heart with its tip approaching a patent foramen ovale between the left atrium and right atrium. -
FIGS. 5-8 illustrate an occluder according to the present invention in a sequence between a reduced profile delivery configuration (FIG. 5 ) and an expanded profile deployed configuration (FIG. 8 ). -
FIG. 9 is an exploded view of components of a delivery system for an occluder in accordance with an embodiment of the present invention. -
FIGS. 10 and 11 are end views of the catch member and inner catheter ofFIG. 9 respectively, as seen along lines 10-10 and 11-11. -
FIG. 12 is a axial cross-sectional detail view of a delivery system with an occluder in accordance with an embodiment of the present invention within a delivery catheter. -
FIGS. 13 and 14 are partial cross-sectional views of a delivery system for an occluder of the present invention. -
FIG. 15 is an exploded view of components of a delivery system and occluder in accordance with another embodiment of the present invention. -
FIGS. 16 and 17 are end views of the catch member and inner catheter ofFIG. 15 respectively, as seen along lines 16-15 and 17-17. -
FIGS. 18A-18C are cross-sectional schematic drawings of another embodiment of the invention with a wire connection between the catch member and the delivery wire. -
FIG. 19 illustrates a schematic view of a catch member according to another embodiment of the invention. -
FIG. 20 illustrates a schematic view of another embodiment of the invention. - In various aspects, the present invention provides devices, delivery/retrieval systems and techniques for delivering such devices intended to occlude an aperture within body tissue. In particular and as described in detail below, the described occluder may be used for closing an ASD, ventricular septal defect (VSD) or PFO in the atrial septum of a heart. Although the embodiments are described with reference to an ASD, VSD or PFO, one skilled in the art will recognize that the device and methods of the present invention may be used to treat other anatomical conditions. As such, the invention should not be considered limited in applicability to any particular anatomical condition. In addition, the systems and methods for delivery and retrieval, and for catching a device in a deployed state, that are aspects of the present invention may also be used in connection with other types of devices besides an occluder, in particular, devices having tubular profiles.
-
FIG. 1 illustrates ahuman heart 10, having aright atrium 11 and aleft atrium 13 and including variousanatomical apertures 18 a and 18 b. Theatrial septum 12 includes septum primum 14 andseptum secundum 16. The anatomy of theseptum 12 varies widely within the population. In some people, septum primum 14 extends to and overlaps withseptum secundum 16. The septum primum 14 may be quite thin. When the anatomical aperture 18 a is present, blood could travel through the anatomical aperture 18 a between septum primum 14 and septum secundum 16 (referred to as “the PFO tunnel”). Additionally or alternatively, blood could travel through theanatomical aperture 18 b (referred to as ASD). - In this application, “distal” refers to the direction away from a catheter insertion location and “proximal” refers to the direction nearer the insertion location. Additionally, the term “delivery configuration” refers to the configuration of a device, such as an occluder, when it has a reduced profile in a delivery catheter. The term “deployed configuration” refers to the configuration of the device, such as an occluder, when it has an expanded profile, such as deployed from the catheter at the desired implantation location.
-
FIG. 2 illustrates an exemplary occluder with which systems and techniques disclosed herein may be used. Anoccluder 70, for example, is illustrated as deployed in theseptum 12 of a heart. Theoccluder 70 operates to close an aperture in the septum by covering the sides of the aperture. The reference numerals used to identify components of the described embodiment are disposed on multiple figures where the component is illustrated. The reference numerals are intended to facilitate an overall understanding of the invention and the relationship between components illustrated in different figures. - The embodiment described in conjunction with
FIGS. 5-8 has some similarities to the device disclosed in or can be used in conjunction with catch mechanisms and delivery/retrieval systems and techniques disclosed in U.S. patent application Ser. No. 10/890,784 entitled Tubular Patent Foramen Ovale (PFO) Closure Device with Catch System filed Jul. 14, 2004; U.S. patent application Ser. No. 11/395,718 entitled Tubular Patent Foramen Ovale (PFO) Closure Device with Catch System filed Mar. 31, 2006; U.S. patent application Ser. No. 11/384,635 entitled Catch Member for PFO Occluder filed Mar. 20, 2006; U.S. patent application Ser. No. 11/235,661 entitled Occluder Device Double Securement System for Delivery/Recovery of Such Occluder Device filed Sep. 26, 2005; U.S. patent application Ser. No. 11/121,833 entitled Catching Mechanisms for Tubular Septal Occluder filed May 4, 2005; U.S. Patent Application No. 60/787, 988 entitled Deformable Flap Catch Mechanism for Occluder Device filed Mar. 31, 2006; U.S. patent application Ser. No. 11/644,373 entitled Catch Members for Occluder Devices filed Dec. 21, 2006; and U.S. patent application Ser. No. 11/728,694 entitled Patent Foramen Ovale (PFO) Closure Device with Linearly Elongating Petals filed Mar. 27, 2007, all of which have the same assignee as the present application and are incorporated herein by reference in their entirety. These incorporated documents describe some ways in which a device can be formed by making cuts or slits in a tube and compressing the ends, and how to deliver such a device. - As shown in
FIGS. 5-8 , theoccluder 70 is formed from a tube (which can be extruded or rolled), or alternately from a plurality of filaments that have been bonded together, that formsdistal petals 72 produced by slits 74 in the distal portion of tube according to the cutting pattern shown inFIG. 5 . As shown inFIG. 6 , thedistal portion 20 of the tube includes eight slits 74 that form eight extended segments of the tube that form the distal loops orpetals 72. As apparent from the figures, the slits extend the entire distance of the distal portion of the tube betweencentral tube 78 anddistal end 76 so that the loops of the same cross-section are formed. Upon application of force Fd todistal end 76, extended segments defined by slits 74 bow and twist outward to formdistal petals 72 in distal side of theoccluder 70. The movement of the segments during deployment is such that the segments may rotate in an orthogonal plane relative to the axis of the device.Central tube 78 may be constrained during the application of force Fd, or any combination of forces sufficient to reduce the axial length of the occluder may be applied. One end of each ofdistal petals 72 originates fromcentral tube 78, while the other end originates from distal end 76 (FIGS. 6 and 7 ).Proximal petals 82 may be formed in theproximal portion 40, as shown inFIGS. 6-8 , by makingslits 84 betweencentral tube 78 andproximal end 86, using the same cutting pattern described above and applying force Fp or a combination of forces sufficient to reduce the axial length of thetube allowing slits 84 to bow and twist outward to formproximal petals 82 inproximal portion 40 of theoccluder 70. One end of each ofdistal petals 82 originates fromcentral tube 78, while the other end originates fromproximal end 86. - The tube(s) or
filaments forming occluder 70 may be formed from a biocompatible metal or polymer. In at least some embodiments, theoccluder 70 is formed of a bioabsorbable polymer, or a shape memory polymer. Shape memory polymers can be advantageous so that the structure of the device assists in pressing the PFO tunnel closed. In other embodiments, theoccluder 70 is formed of a biocompatible metal, such as a shape memory alloy (e.g., nitinol). The thermal shape memory and/or superelastic properties of shape memory polymers and alloys permit theoccluder 70 to resume and maintain its intended shape in vivo despite being distorted during the delivery process. Alternatively, or additionally, theoccluder 70 may be formed of a bioabsorbable metal, such as iron, magnesium, or combinations of these and similar materials. Exemplary bioabsorbable polymers include polyhydroxyalkanoate compositions, for example poly-4-hydroxybutyrate (P4HB) compositions, disclosed in U.S. Pat. No. 6,610,764, entitled Polyhydroxyalkanoate Compositions Having Controlled Degradation Rate and U.S. Pat. No. 6,548,569, entitled Medical Devices and Applications of Polyhydroxyalkanoate Polymers, both of which are incorporated by reference in their entirety. - The cross-sectional shape of the tube may be circular or polygonal, for example square, or hexagonal. The
slits 74, 84 may be disposed on the face of the polygon (i.e., the flat part) or on the intersection of the faces. - The tube can be injection molded, extruded, or constructed of a sheet of material and rolled into a tube. The sheet of material could be a single ply sheet or multiple ply. The slits that form the segments could be cut or stamped into the sheet prior to rolling the sheet into a tube to connect the ends to form an enclosed cross section. Various geometrical cross sections are possible including circular, square, hexagonal and octagonal and the joint could be at the vertex or along the flat of a wall if the cross section is of a particular geometry. Various attachment techniques could be used to join the ends of the sheet to form a tube, including welding, heat adhesives, non-heat adhesives and other joining techniques suitable for in vivo application.
- The petal configuration, illustrated in
FIG. 8 , is the deployed configuration. Theoccluder 70 can be secured in the deployed configuration by a catch system that holds the ends of the tube together, certain embodiments of which are described below. - The transformable design of
occluder 70 enablesoccluder 70 to be delivered in a reduced profile, delivery configuration and to be converted readily, i.e., by reducing the axial length, in place to the expanded profile deployed configuration. Moreover, the conversion can readily be effected by forcingdistal end 76 andproximal end 86 to move toward each other. For example,distal portion 20 andproximal portion 40 ofoccluder 70 may be deployed in separate steps, or bothdistal portion 20 andproximal portion 40 ofoccluder 70 may be exposed (e.g., out of the delivery catheter) prior to engaging the catch system and deployed together as the catch element is engaged. Use of the terms distal andproximal portion -
Occluder 70 may be made in any one of several ways.Slits 74 and 84 may be cut such that tube bends into its intended configuration following deployment in vivo. Specifically, slits 74 and 84 may be cut to producesegments 72 and 82 (as illustrated inFIGS. 5 , 6) of a thickness that facilitates the bending and formation ofloops 72 and 82 (as illustrated inFIGS. 7 , 8) upon the application offerees Fd and/or Fp during deployment. Thesegments occluder 70 in vivo. An intermediate approach may also be used: tube may be only slightly preformed ex vivo such that it is predisposed to bend into its intended shape in vivo upon application offerees Fd and/or Fp. An occluder formed from filaments can similarly be preformed ex vivo. -
FIG. 2 shows a deployedoccluder 70 in a human heart with acatch member 50 engaged (much of the catch member is obscured by the central tube of the occluder). The term “catch system” describes the components or portions/aspects of a device that secures the occluder in the deployed configuration; it may be a single piece or a group of connected or assembled pieces. In embodiments described herein, a catch system includes a catch member substantially disposed within an axial passage of the occluder that engages with the ends of the occluder to hold the occluder in the deployed configuration. The axial passage can be radially central in some embodiments. The catch member is described in more detail below. This particular type ofoccluder 70 and delivery sequences are described for purposes of illustration and explanation; of course, other types of occluders can be deployed using the catch systems described herein. - The
catch member 50, as illustrated, is disposed in a radially central location in theoccluder 70 and is schematically illustrated as a separate piece than theoccluder 70. In a preferred embodiment, the distal end of the catch member includes a flange 92 (shown inFIGS. 6-8 ) that rests against, but not fixed to, thedistal end 76 of theoccluder 70. When thecatch member 50 is pulled in the proximal direction, theflange 92 applies a force Fd to thedistal end 76 of theoccluder 70 and moves it in the proximal direction. In general, references to “occluder 70” herein may be inclusive ofcatch member 50, depending on the context, for example, unless separately listed or otherwise stated. - One end of the occluder, preferably the
proximal end 86 of theoccluder 70, is able to move with respect to the catch member 50 (and especially the catch system provided thereby) so that the distal andproximal petals catch member 50 is connected with theproximal end 86 of theoccluder 70, the occluder is secured in its deployed configuration. -
FIG. 3 illustrates the insertion of an occluder in ahuman subject 122 using adelivery assembly 124 in accordance with an aspect of the disclosure. A portion ofdelivery assembly 124, including an occluder and a delivery mechanism for the occluder, which can be externally manipulated by a clinician, is inserted into the subject through anincision point 126. The distal end of the delivery assembly is advanced toward and into theheart 10 until the distal end is in proximity to the defect to be closed, as seen inFIG. 4 . - One embodiment of a
delivery system 250 of the present invention will now be described with reference toFIGS. 9-12 . As used herein, when connected to an occluder and/or catch member, the term “delivery system” may include those components.FIG. 9 is an exploded perspective view of the components of thedelivery system 250 including acatch member 50 that can be disposed in the radially central portion of theoccluder 70. The illustratedsystem 250 further includes adelivery catheter 172 with itsdistal end 178 for holding theproximal end 86 of theoccluder 70 during its delivery, deployment, and retrieval, aninner catheter 168 slidably disposed within thedelivery catheter 172 with a key 166 at its distal end, and adelivery wire 164 slidably disposed within theinner catheter 168 designated to connect with thecatch member 50 with a threadedportion 162 at its distal end. Thecatch member 50 includesflange 92 at the distal end. Theflange 92 rests against thedistal end 76 of theoccluder 70, so that when a force Fd is applied to catchmember 50, the distal end of theoccluder 70 moves along withcatch member 50 in the proximal direction. The distal end of thecatch member 50 is allowed to freely rotate relative to theoccluder 70, for reasons that are made clear as the operation of the device is described below. Typically thecatch member 50 has an axial length of about 5-30 mm and a diameter of approximately 0.5-3 mm. The axial length of thecatch member 50 is related to the axial length of the occluder in the deployed configuration. Although thecatch member 50 is illustrated as a circular cylinder, a variety of cross-sectional shapes can be used effectively. - According to one embodiment,
catch member 50 is made of any metal or polymer. In another embodiment,catch member 50 is made of biocompatible metal or polymer. In an alternative embodiment,catch member 50 is made of bioabsorbable or shape memory material. - In a specific embodiment,
catch member 50 is made of shape memory material (e.g., nitinol). The thermal shape memory and/or superelastic properties of shape memory polymers and alloys permit thecatch member 50 to resume and maintain its intended shape in vivo despite being distorted during the delivery and/or deployment process. - In one embodiment,
catch member 50 is made of a bioabsorbable material. Exemplary bioabsorbable materials include polymers, such as polyhydroxyalkanoate compositions, for example poly-4-hydroxybutyrate (P4HB) compositions, disclosed in U.S. Pat. No. 6,610,764, entitled Polyhydroxyalkanoate Compositions Having Controlled Degradation Rate and U.S. Pat. No. 6,548,569, entitled Medical Devices and Applications of Polyhydroxyalkanoate Polymers, both of which are incorporated by reference in their entirety. - The
proximal end 160 of thecatch member 50 includesexternal threads 152 that cooperate withinternal threads 154 of theproximal end 86 of theoccluder 70. When engaged, the threaded connection formed bythreads occluder 70 in the deployed configuration. The connection can be released by unthreading thecatch member 50 from the proximal end of theoccluder 70. Once the connection is released, theoccluder 70 can collapse into its delivery configuration and be retrieved. - In the illustrated embodiment, The
proximal end 160 of thecatch member 50 also includesinternal threads 158 and a slot 156 (shown in dashed lines) disposed at the radial center of thecatch member 50. In other embodiments, theinternal threads 158 can be disposed anywhere along the length ofcatch member 50, i.e., at the proximal or distal ends or more centrally. Theinternal threads 158 are designed to cooperate withexternal threads 162 of the distal end of thedelivery wire 164. When engaged, the threaded connection formed bythreads catch member 50 when thedelivery wire 164 is pulled in the proximal direction. To release the delivery wire after the deployment of theoccluder 70, the threaded connection betweenthreads - In addition to the threaded
portion 154 at theproximal end 86 of theoccluder 70 to secure, thecatch member 50, the occluder can include additional internal threads at the center joint orconnection member 78. For example, as illustrated, theconnection member 78 may havethreads 79 that can cooperate with thethreads 152 on thecatch member 50 to secure the occluder in an intermediate position. Of course, as with all the embodiments, the number of threads can vary. That is, more or fewer threads can be provided than illustrated in the exemplary embodiment. - Other mechanisms for connecting the
delivery wire 164 andcatheter 168 are also possible. AlthoughFIG. 9 shows thedelivery wire 164 designed to connect with thecatch member 50 by a threaded connection, the connection between thedelivery wire 164 and thecatch member 50 can be any other suitable mechanism as described in, for example, U.S. patent application Ser. No. 11/235,661, incorporated by reference herein in its entirety. In specific embodiments, thedelivery wire 164 can also be connected with thecatch member 50 by any other suitable means, including various types of wire or other long flexible material. For ease of reference, the delivery wire is intended to include all long, flexible materials that are suitable for the intended purpose described. In some embodiments, it may be advantageous to have the delivery wire be able to translate an axial pushing force. If a sufficiently thin material is used, thedelivery wire 164 can be cut to release thedelivery wire 164 after the deployment of theoccluder 70. Other embodiments are described below. - The
delivery wire 164 is disposed insideinner catheter 168 and can freely slide or rotate relative to theinner catheter 168. Theinner catheter 168 is slidably disposed within thedelivery catheter 172. Theinner catheter 168 can also extend inside the radially central portion ofoccluder 70 and can freely rotate or slide relative to theoccluder 70. Disposed at thedistal end 170 of theinner catheter 168 is a key 166 that can be inserted into theslot 156 at theproximal end 160 of thecatch member 50. When inserted, the key 166 of theinner catheter 168 fits theslot 156 at theproximal end 160 of thecatch member 50, so that by rotating theinner catheter 168, thecatch member 50 can be rotated. Hence, upon inserting the key 166 of theinner catheter 168 to theslot 156 at theproximal end 160 of thecatch member 50, theinner catheter 168 can be used to threadably engage or disengage theexternal threads 152 at theproximal end 160 of thecatch member 50 withinternal threads 154 of theoccluder 70. -
FIGS. 10 and 11 are end views of the catch member and inner catheter of thedelivery system 250 illustrated inFIG. 9 , as seen along lines 10-10 and 11-11 respectively. Although the cross-section of the key 166 of theinner catheter 168 and theslot 156 at theproximal end 160 of thecatch member 50 are shown as squares, a variety of cross-sectional shapes can be used effectively. - The delivery system includes a
delivery catheter 172 for holding theproximal end 86 of theoccluder 70 during the deployment or retrieval of theoccluder 70. Thedistal end 178 of thedelivery catheter 172 includesinternal threads 174 that cooperate withexternal threads 176 at theproximal end 86 of the occluder. Thedelivery catheter 172 can be threadably connected to theoccluder 70 usingthreads distal end 76 of theoccluder 70, thedelivery catheter 172 can hold the position of theproximal end 86 of theoccluder 70, or apply a force Fp in the opposite direction of force Fd, so that the axial length of theoccluder 70 is reduced and theoccluder 70 is transformed from the delivery configuration into the deployed configuration. Once theoccluder 70 is deployed, thedelivery catheter 172 can be disconnected from theoccluder 70 and removed. - Although
FIG. 9 shows thedelivery catheter 172 designed to connect with theoccluder 70 by a threaded connection, the connection between thedelivery catheter 172 and the occluder can be any other suitable mechanism as described in, for example, U.S. patent application Ser. No. 11/235,661, incorporated by reference herein in its entirety. -
FIG. 12 is a cross-sectional detail view of the delivery system,catch member 50 and theoccluder 70 illustrated inFIGS. 9-11 within adelivery sheath 200. As shown, thedelivery catheter 172 is connected with theproximal end 86 of theoccluder 70. Theinner catheter 168 is in contact with theproximal end 160 of thecatch member 50, with the key 166 at the distal end inserted into theslot 156 at theproximal end 160 of thecatch member 50. Thedelivery wire 164 is disposed inside theinner catheter 168 and is shown in phantom lines. Thedelivery wire 164 is attached to theproximal end 160 of thecatch member 50. Theflange 92 at the distal end of thecatch member 50 is in contact with thedistal end 76 of theoccluder 70. Theoccluder 70 is in a reduced profile, delivery configuration so that it fits within thedelivery sheath 200. Using thedelivery sheath 200, theoccluder 70 and thecatch member 50 can be inserted into or retrieved from a human subject as illustrated inFIG. 3 . - As illustrated in
FIG. 12 , various components of the delivery system, thecatch member 50 and theoccluder 70 can be connected and placed inside thedelivery sheath 200 before deployment. After moving the distal end of thedelivery sheath 200 past an aperture in the septum, thedelivery sheath 200 can be removed, exposing theoccluder 70. Thedelivery wire 164 and thedelivery catheter 172 can then be used to convert theoccluder 70 from the delivery configuration to the expanded profile, deployed configuration to occlude the aperture. Theinner catheter 168 anddelivery wire 164 can then be used to connect and engage the proximal ends 160 of thecatch member 50 and proximal ends 86 of theoccluder 70 so that theoccluder 70 maintains the deployed configuration. Then, thedelivery catheter 172 andinner catheter 168 can be detached from theoccluder 70 and removed. With thedelivery wire 164 still connected to thecatch member 50, the deployment of theoccluder 70 can now be assessed. If deployment of theoccluder 70 is not satisfactory, theoccluder 70 can be retrieved. Upon satisfaction with the deployment of theoccluder 70, thedelivery wire 164 can be removed. In an alternate sequence, thedelivery wire 164 andinner catheter 168 can be detached fromoccluder 70 first. The position can be assessed with thedelivery catheter 172 in place. Thedelivery catheter 172 can then be removed. - If retrieval is needed, the
inner catheter 168 can be disposed inside thedelivery catheter 172, which can be disposed inside thedelivery sheath 200 and advanced together into the heart. In addition, thedelivery wire 164 can be disposed inside theinner catheter 168 and inserted together with theinner catheter 168. Thedelivery catheter 172 engages theproximal end 86 of theoccluder 70, and thedelivery wire 164 engages theproximal end 160 of thecatch member 50. Theinner catheter 168 anddelivery wire 164 is used to rotate thecatch member 50 to disengage itsproximal end 160 from theproximal end 86 of theoccluder 70. After theoccluder 70 returns to its reduced profile, delivery configuration, theoccluder 70 and thecatch member 50 can be withdrawn together with thedelivery sheath 200. -
FIGS. 13 and 14 are partial cross-sectional views of adelivery assembly 124 in accordance with an aspect of the disclosure.Delivery assembly 124 includes anoccluder 70 and acatch member 50 at the distal end. As shown inFIG. 13 ,delivery assembly 124 has four coaxial components, which make up thedelivery system 250, disposed next to theoccluder 70, which are thedelivery wire 164, theinner catheter 168, thedelivery catheter 172, and thedelivery sheath 200. AsFIG. 14 illustrates, thedelivery wire 164, theinner catheter 168, thedelivery catheter 172, and thedelivery sheath 200 can all freely slide and rotate with respect to each other. The motion of these components can be controlled by anapparatus 202 disposed at the proximal end of thedelivery assembly 124.Apparatus 202 can be manipulated externally from the body by a clinician. -
FIG. 14 illustrates the types of movement possible at the proximal end of the delivery system that can deploy theoccluder 70 with acatch member 50 according to an embodiment of the present invention. As illustrated inFIG. 14 , one embodiment of the invention can be delivered by the use of a delivery system that can be manipulated in several axial (back and forth) and rotational (around an axis) directions. Particularly, thedelivery sheath 200 can be moved axially by movement D and (optionally) rotationally by the movement H. Directional arrows at the proximal side illustrate the direction of movement an operator would effect to move in the same direction at the distal side. The proximal portion is on the upper part ofFIG. 14 and the distal side is on the lower portion ofFIG. 14 . Thedelivery catheter 172 can be moved axially by movement A and rotationally by movement E. Theinner catheter 168 can be moved in the axial direction by movement B and rotationally by movement G. Finally, thedelivery wire 164 can be moved axially by movement C and rotationally by movement F. Of course, various combinations of movements are possible and desirable, for example during delivery of theoccluder 70 to the desired delivery site through the blood vessels, all the components will be moved together. -
FIG. 15 is an expanded view of adelivery system 300 in accordance with another embodiment of the present invention. Similar to thedelivery system 250 illustrated inFIGS. 9-12 , thisdelivery system 300 includes acatch member 256 that can be disposed in the radially central portion of theoccluder 70, adelivery catheter 252 with itsdistal end 178 for holding theproximal end 86 of theoccluder 70 during its delivery, deployment, and retrieval, aninner catheter 258 slidably disposed within thedelivery catheter 252 with aslot 274 at its distal end, and adelivery wire 260 slidably disposed within theinner catheter 258 designed to connect with thecatch member 256. Theproximal end 254 of thecatch member 256 includesexternal threads 264 that cooperate withinternal threads 266 of theproximal end 86 of theoccluder 70. When engaged, the threadedconnection occluder 70 in the deployed configuration. When theproximal end 254 of thecatch member 256 and theproximal end 86 of theoccluder 70 are disengaged, theoccluder 70 can collapse into its reduced profile, delivery configuration and be retrieved. Thecatch member 256 includes aflange 262 at the distal end that rests against thedistal end 76 of theoccluder 70. - Different from the
delivery system 250 shown inFIG. 9 , thedelivery wire 260 engages thecatch member 256 by forming a loop around the distal end of thecatch member 256. As illustrated, two apertures may be formed within thecatch member 256 to secure thedelivery wire 260. As illustrated inFIG. 18A , in this embodiment, thecatch member 256 includes anaxial passageway 268 sufficient to allow the wire to be disposed within. The distal end of thecatch member 256 has twoapertures 270 which communicate with the axial passageway. Thedelivery wire 260 extends distally through the first aperture, bends, and returns through the second aperture. During occluder delivery, the distal end of thedelivery wire 260 extends to a general proximal direction. By pulling thedelivery wire 260 in the proximal direction, a force Fd can be applied to thecatch member 256 and thedistal end 76 of theoccluder 70. After the deployment of theoccluder 70, thedelivery wire 260 can be removed. - An
inner catheter 258 is disposed inside the central portion of theoccluder 70 and can freely rotate or slide relative to theoccluder 70. The distal end of theinner catheter 258 includes aslot 274 that fits a key 272 disposed at the proximal end of thecatch member 256. Using theinner catheter 258, thecatch member 256 can therefore be rotated to engage theproximal end 86 of theoccluder 70 locking the occluder in the deployed configuration. Thisdelivery system 300 can be used to deployoccluder 70 in generally the same manner as the delivery system described in connection withFIGS. 9-12 . -
FIGS. 16 and 17 are end views of the catch member and inner catheter of thedelivery system 300 as seen along lines 16-16 and 17-17, ofFIG. 15 , respectively. The cross-sectional shape of the key 272 at the proximal end of thecatch member 256 and theslot 274 of theinner catheter 258 are not limited to what is illustrated inFIGS. 15-17 ; various other cross-sectional shapes can be used effectively. -
FIGS. 18A-18C illustrate the function of thedelivery wire 260 during occluder delivery and its removal after occluder deployment. As illustrated in detail cross-sectional view, with similar reference numerals being given an “a”. For example, the catch member is “50 a”. In this embodiment adelivery wire 260 is provided that can transmit a pushing force along its axial length so that a pushing force applied at the proximal end of thedelivery wire 260 can push thedelivery wire 260 distally. Thedelivery wire 260 is disposed in anaxial passageway 352 in the catch member 50 a. Thedelivery wire 260 extends distally through thefirst aperture 354, bends, and returns through thesecond aperture 356. During occluder deployment, catch member 50 a extends proximally by a pulling force Ttensilewire, and thedelivery wire 260 remains in place in the aperture as illustrated inFIG. 18A . To removedelivery wire 260, as illustrated inFIG. 18B , a force Tpushwire is applied, thedelivery wire 260 extends distally. Distal end of thedelivery wire 260 is then freed from the second aperture, and therefore thedelivery wire 260 is disconnected with the catch member 50 a. Then, a force Tpullwire is applied, thedelivery wire 260 is removed as illustrated inFIG. 18C . In some embodiments, the delivery wire material could be 304SS stainless steel flat wire or nitinol. -
FIG. 19 illustrates another embodiment of a catch member 50 b that can be used with various embodiments of the invention described herein. In this embodiment, theoccluder 70 is designated with numbers consistent with previous embodiments. A catch member 50 b includes a flange orridge 360 at the proximal side of thedistal end 76 in addition to adistal flange 92 b. According to this embodiment, theflanges distal end 76 of the occluder with respect to catch member 50 b. The catch member 50 b may be allowed to rotate with respect to the occluder or not depending on the configuration of other parts of the catch system. In a preferred embodiment, theridge 360 is disposed adjacent to the distal end of the catch member 50 b. The distance between theridge 360 and thedistal flange 92 b is approximately equal to the axial length of the tubulardistal end 76 of theoccluder 70. Theridge 360 has a radial size approximately equal to thedistal flange 92 b, but the size could be smaller or larger in various embodiments. Thecenter ridge 360 facilitates pushing of thedistal end 76 if retrieval of theoccluder 70 is desired. Thecenter ridge 360 thus can be used to collapse theoccluder 70. - It will be understood that the
threads FIG. 20 illustrates an embodiment of the invention such that the threadedportions catch member 50 to the tube does not extend the entire axial distance of theproximal end 86 c. In another embodiment, the threaded portion does extend the entire axial distance of theproximal end 86 c. In another embodiment, the threaded portion extends the entire length of thecatch member 50. - The embodiments and techniques described here are described preferably for use with a device made of a polymer and formed from a single tube. While the device is thus shown as being substantially formed from a single tubular body, which could also be made of cylindrically arranged filaments, the catch mechanism as described in the embodiments above could be used with other types of devices, including those formed from many pieces, and including devices formed from other materials, including metals, polymers, stainless steel or nitinol.
- The term “bioabsorbable,” as used in the description above, is also understood to mean “bioresorbable.”
- While the description above refers to “wires”, and while the term “wire” might convey a more rigid piece than a string, a suture or a filament, all these terms are essentially interchangeable with respect to the invention and any suitable element can be used. Each wire, string, suture and filament can be composed of one or more wires, strings, sutures and filaments.
- In cases in which the device is made of a polymer, it can be desirable to add an additive or coating to the material to make it radiopaque to make it more visible in a wider variety of imaging techniques.
- It will be appreciated that while a particular sequence of steps has been shown and described for purposes of explanation, the sequence may be varied in certain respects, or the steps may be combined, while still obtaining the desired deployment or in some cases to effect deployment in a particular way. For example, the delivery sheath may be advanced or retracted at varying times and in varying degrees, the proximal and distal portions of the occluder may be deployed into the petal configuration in a different sequence, etc. In addition, the steps could be automated.
- It will be appreciated that the particular embodiments illustrated and described herein are provided by way of example only and are not intended to limit the scope of the invention, which is indicated in the appended claims.
Claims (1)
1. A method for deploying a medical device having a first, delivery configuration and a second, deployed configuration, to an aperture in the body comprising:
introducing a delivery system, including the medical device, the medical device having a distal side and a proximal side and a catch member, to a desired location in the body, the catch member having a first external threads and the medical device having a first internal threads;
deploying a distal side of the medical device on a distal side of the aperture;
deploying a proximal side of the medical device on a proximal side of the aperture;
rotating the catch member relative to the medical device to cause the first external threads disposed on the catch member to engage the first internal threads disposed on the medical device, whereby the medical device is held in the second configuration; and
releasing the medical device from the delivery system.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/026,896 US20140018848A1 (en) | 2006-03-31 | 2013-09-13 | Screw Catch Mechanism for PFO Occluder and Method of Use |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78798706P | 2006-03-31 | 2006-03-31 | |
US11/729,045 US8551135B2 (en) | 2006-03-31 | 2007-03-28 | Screw catch mechanism for PFO occluder and method of use |
US14/026,896 US20140018848A1 (en) | 2006-03-31 | 2013-09-13 | Screw Catch Mechanism for PFO Occluder and Method of Use |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/729,045 Division US8551135B2 (en) | 2006-03-31 | 2007-03-28 | Screw catch mechanism for PFO occluder and method of use |
Publications (1)
Publication Number | Publication Date |
---|---|
US20140018848A1 true US20140018848A1 (en) | 2014-01-16 |
Family
ID=38370411
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/729,045 Active US8551135B2 (en) | 2006-03-31 | 2007-03-28 | Screw catch mechanism for PFO occluder and method of use |
US14/026,896 Abandoned US20140018848A1 (en) | 2006-03-31 | 2013-09-13 | Screw Catch Mechanism for PFO Occluder and Method of Use |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/729,045 Active US8551135B2 (en) | 2006-03-31 | 2007-03-28 | Screw catch mechanism for PFO occluder and method of use |
Country Status (4)
Country | Link |
---|---|
US (2) | US8551135B2 (en) |
EP (1) | EP2001368B1 (en) |
ES (1) | ES2588687T3 (en) |
WO (1) | WO2007115114A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9916825B2 (en) | 2015-09-29 | 2018-03-13 | Yandex Europe Ag | Method and system for text-to-speech synthesis |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2847151B1 (en) * | 2002-11-15 | 2005-01-21 | Claude Mialhe | OCCLUSIVE DEVICE WITH MEDICAL OR SURGICAL DESTINATION |
EP1651116B1 (en) | 2003-07-14 | 2013-06-26 | W.L. Gore & Associates, Inc. | Tubular patent foramen ovale (pfo) closure device with catch system |
US9861346B2 (en) | 2003-07-14 | 2018-01-09 | W. L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure device with linearly elongating petals |
US8480706B2 (en) | 2003-07-14 | 2013-07-09 | W.L. Gore & Associates, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
EP1891902A1 (en) * | 2006-08-22 | 2008-02-27 | Carag AG | Occluding device |
WO2008042229A2 (en) * | 2006-09-28 | 2008-04-10 | Nmt Medical, Inc. | Implant-catheter attachment mechanism using snare and method of use |
WO2008124603A1 (en) | 2007-04-05 | 2008-10-16 | Nmt Medical, Inc. | Septal closure device with centering mechanism |
WO2009052432A2 (en) | 2007-10-19 | 2009-04-23 | Coherex Medical, Inc. | Medical device for modification of left atrial appendange and related systems and methods |
US20130165967A1 (en) | 2008-03-07 | 2013-06-27 | W.L. Gore & Associates, Inc. | Heart occlusion devices |
WO2010081033A1 (en) | 2009-01-08 | 2010-07-15 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US9351716B2 (en) | 2009-06-17 | 2016-05-31 | Coherex Medical, Inc. | Medical device and delivery system for modification of left atrial appendage and methods thereof |
US10064628B2 (en) | 2009-06-17 | 2018-09-04 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US10631969B2 (en) | 2009-06-17 | 2020-04-28 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
CN105640606B (en) | 2009-06-17 | 2018-10-09 | 科赫里克斯医疗股份有限公司 | Medical treatment device for correcting left auricle of heart and relevant system and method |
US9649115B2 (en) | 2009-06-17 | 2017-05-16 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US20120029556A1 (en) | 2009-06-22 | 2012-02-02 | Masters Steven J | Sealing device and delivery system |
US8956389B2 (en) | 2009-06-22 | 2015-02-17 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
CH701394A2 (en) * | 2009-07-10 | 2011-01-14 | Carag Ag | Occluder. |
SG10201913438WA (en) * | 2009-12-17 | 2020-03-30 | Univ Nanyang Tech | Occlusion Device for Closing Anatomical Defects |
DE102010016803A1 (en) * | 2010-05-05 | 2011-11-10 | Aesculap Ag | Medical fixing device comprises fixing element which is provided with distal end section, where inserting position is converted in fixed position by approaching distal end section relative to proximal end section |
WO2015134768A1 (en) * | 2011-01-11 | 2015-09-11 | Amsel Medical Corporation | Method and apparatus for occluding a blood vessel and/or other tubular structures |
US20130035721A1 (en) * | 2011-08-04 | 2013-02-07 | John Eric Brunelle | Surgical anchor |
US9770232B2 (en) | 2011-08-12 | 2017-09-26 | W. L. Gore & Associates, Inc. | Heart occlusion devices |
EP3682813B1 (en) | 2011-11-01 | 2023-12-27 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage |
CN104334117A (en) * | 2012-01-26 | 2015-02-04 | 恩多沙普公司 | Systems, devices, and methods for delivering a lumen occlusion device using distal and/or proximal control |
CA2879882A1 (en) * | 2012-07-23 | 2014-01-30 | University Of Utah Research Foundation | Indwelling urinary catheter |
US10828019B2 (en) | 2013-01-18 | 2020-11-10 | W.L. Gore & Associates, Inc. | Sealing device and delivery system |
US10028746B2 (en) | 2013-03-08 | 2018-07-24 | St. Jude Medical, Cardiology Division, Inc. | Medical device for treating a target site |
US10973523B2 (en) * | 2013-03-08 | 2021-04-13 | Aga Medical Corporation | Medical device for treating a target site |
US9808230B2 (en) | 2014-06-06 | 2017-11-07 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US9757134B2 (en) | 2014-06-12 | 2017-09-12 | Cook Medical Technologies Llc | System for delivery and deployment of an occluder and method |
US10441259B2 (en) * | 2015-02-27 | 2019-10-15 | Surgical Innovations Llc | Wound closure apparatus and method |
US9615817B2 (en) * | 2015-02-27 | 2017-04-11 | Surgical Innovations Llc | Wound closure apparatus and method |
US10595840B2 (en) * | 2015-02-27 | 2020-03-24 | Surgical Innovations Llc | Wound closure apparatus and method |
WO2018053314A1 (en) | 2016-09-16 | 2018-03-22 | Greg Mirigian | Occlusive implants with fiber-based release structures |
EP3694423A4 (en) * | 2017-10-13 | 2021-08-04 | Amsel Medical Corporation | Apparatus and methods for clamping tissue layers and occluding hollow vessels |
WO2020207484A1 (en) * | 2019-04-11 | 2020-10-15 | 杭州唯强医疗科技有限公司 | Occluder, occluder fastening system and fastening method |
US11369355B2 (en) | 2019-06-17 | 2022-06-28 | Coherex Medical, Inc. | Medical device and system for occluding a tissue opening and method thereof |
WO2021101622A1 (en) | 2019-11-21 | 2021-05-27 | W. L. Gore & Associates, Inc. | Delivery systems and methods for implantable cardiac assist devices |
US20210236102A1 (en) * | 2020-02-03 | 2021-08-05 | St. Jude Medical, Cardiology Division, Inc. | Occluder locking mechanisms |
US11812969B2 (en) | 2020-12-03 | 2023-11-14 | Coherex Medical, Inc. | Medical device and system for occluding a tissue opening and method thereof |
Family Cites Families (274)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3874388A (en) * | 1973-02-12 | 1975-04-01 | Ochsner Med Found Alton | Shunt defect closure system |
US3875648A (en) * | 1973-04-04 | 1975-04-08 | Dennison Mfg Co | Fastener attachment apparatus and method |
US3824631A (en) | 1973-05-11 | 1974-07-23 | Sampson Corp | Bone joint fusion prosthesis |
US3924631A (en) | 1973-12-06 | 1975-12-09 | Altair Inc | Magnetic clamp |
US4006747A (en) * | 1975-04-23 | 1977-02-08 | Ethicon, Inc. | Surgical method |
US4007743A (en) * | 1975-10-20 | 1977-02-15 | American Hospital Supply Corporation | Opening mechanism for umbrella-like intravascular shunt defect closure device |
CH598398A5 (en) * | 1976-07-21 | 1978-04-28 | Jura Elektroapparate Fab | |
US4425908A (en) * | 1981-10-22 | 1984-01-17 | Beth Israel Hospital | Blood clot filter |
JPS6171065A (en) | 1984-09-13 | 1986-04-11 | テルモ株式会社 | Catheter introducer |
US4696300A (en) | 1985-04-11 | 1987-09-29 | Dennison Manufacturing Company | Fastener for joining materials |
US4738666A (en) | 1985-06-11 | 1988-04-19 | Genus Catheter Technologies, Inc. | Variable diameter catheter |
US4710181A (en) | 1985-06-11 | 1987-12-01 | Genus Catheter Technologies, Inc. | Variable diameter catheter |
US4626245A (en) | 1985-08-30 | 1986-12-02 | Cordis Corporation | Hemostatis valve comprising an elastomeric partition having opposed intersecting slits |
US4710192A (en) | 1985-12-30 | 1987-12-01 | Liotta Domingo S | Diaphragm and method for occlusion of the descending thoracic aorta |
US4693249A (en) | 1986-01-10 | 1987-09-15 | Schenck Robert R | Anastomosis device and method |
EP0253365B1 (en) | 1986-07-16 | 1991-11-27 | Sumitomo Chemical Company, Limited | Rubber composition |
US5478353A (en) | 1987-05-14 | 1995-12-26 | Yoon; Inbae | Suture tie device system and method for suturing anatomical tissue proximate an opening |
US5250430A (en) | 1987-06-29 | 1993-10-05 | Massachusetts Institute Of Technology | Polyhydroxyalkanoate polymerase |
US5245023A (en) | 1987-06-29 | 1993-09-14 | Massachusetts Institute Of Technology | Method for producing novel polyester biopolymers |
US4836204A (en) * | 1987-07-06 | 1989-06-06 | Landymore Roderick W | Method for effecting closure of a perforation in the septum of the heart |
US4921479A (en) | 1987-10-02 | 1990-05-01 | Joseph Grayzel | Catheter sheath with longitudinal seam |
US4840623A (en) * | 1988-02-01 | 1989-06-20 | Fbk International Corporation | Medical catheter with splined internal wall |
IT1216042B (en) * | 1988-03-09 | 1990-02-22 | Carlo Rebuffat | AUTOMATIC TOOL FOR TOBACCO BAG SUTURES FOR SURGICAL USE. |
US4956178A (en) | 1988-07-11 | 1990-09-11 | Purdue Research Foundation | Tissue graft composition |
US4902508A (en) * | 1988-07-11 | 1990-02-20 | Purdue Research Foundation | Tissue graft composition |
US4917089A (en) | 1988-08-29 | 1990-04-17 | Sideris Eleftherios B | Buttoned device for the transvenous occlusion of intracardiac defects |
FR2641692A1 (en) * | 1989-01-17 | 1990-07-20 | Nippon Zeon Co | Plug for closing an opening for a medical application, and device for the closure plug making use thereof |
US5245080A (en) | 1989-02-20 | 1993-09-14 | Jouveinal Sa | (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-N-propylamine, process for preparing it and its therapeutical use |
US5620461A (en) * | 1989-05-29 | 1997-04-15 | Muijs Van De Moer; Wouter M. | Sealing device |
US5049131A (en) | 1989-05-31 | 1991-09-17 | Ashridge Ag | Balloon catheter |
US5149327A (en) | 1989-09-05 | 1992-09-22 | Terumo Kabushiki Kaisha | Medical valve, catheter with valve, and catheter assembly |
US5163131A (en) | 1989-09-08 | 1992-11-10 | Auspex Systems, Inc. | Parallel i/o network file server architecture |
US5226879A (en) | 1990-03-01 | 1993-07-13 | William D. Ensminger | Implantable access device |
US5453099A (en) | 1990-03-26 | 1995-09-26 | Becton, Dickinson And Company | Catheter tubing of controlled in vivo softening |
DE69102515T2 (en) | 1990-04-02 | 1994-10-20 | Kanji Inoue | DEVICE FOR CLOSING A SHUTTER OPENING BY MEANS OF A NON-OPERATIONAL METHOD. |
US5078736A (en) * | 1990-05-04 | 1992-01-07 | Interventional Thermodynamics, Inc. | Method and apparatus for maintaining patency in the body passages |
US5021059A (en) * | 1990-05-07 | 1991-06-04 | Kensey Nash Corporation | Plug device with pulley for sealing punctures in tissue and methods of use |
US5037433A (en) | 1990-05-17 | 1991-08-06 | Wilk Peter J | Endoscopic suturing device and related method and suture |
US20020032459A1 (en) * | 1990-06-20 | 2002-03-14 | Danforth Biomedical, Inc. | Radially-expandable tubular elements for use in the construction of medical devices |
US5041129A (en) | 1990-07-02 | 1991-08-20 | Acufex Microsurgical, Inc. | Slotted suture anchor and method of anchoring a suture |
CA2093821A1 (en) | 1990-10-09 | 1992-04-10 | Walter R. Pyka | Device or apparatus for manipulating matter |
JPH04170966A (en) | 1990-11-01 | 1992-06-18 | Nippon Sherwood Kk | Valvular body for catheter introducer blood stop valve |
US5108420A (en) | 1991-02-01 | 1992-04-28 | Temple University | Aperture occlusion device |
US5176659A (en) | 1991-02-28 | 1993-01-05 | Mario Mancini | Expandable intravenous catheter and method of using |
US5257637A (en) | 1991-03-22 | 1993-11-02 | El Gazayerli Mohamed M | Method for suture knot placement and tying |
CA2082090C (en) * | 1991-11-05 | 2004-04-27 | Jack Fagan | Improved occluder for repair of cardiac and vascular defects |
EP0545091B1 (en) | 1991-11-05 | 1999-07-07 | The Children's Medical Center Corporation | Occluder for repair of cardiac and vascular defects |
US5282827A (en) * | 1991-11-08 | 1994-02-01 | Kensey Nash Corporation | Hemostatic puncture closure system and method of use |
US5222974A (en) * | 1991-11-08 | 1993-06-29 | Kensey Nash Corporation | Hemostatic puncture closure system and method of use |
US5935122A (en) | 1991-12-13 | 1999-08-10 | Endovascular Technologies, Inc. | Dual valve, flexible expandable sheath and method |
DE69324239T2 (en) * | 1992-01-21 | 1999-11-04 | Univ Minnesota | SEPTUAL DAMAGE CLOSURE DEVICE |
US5649950A (en) | 1992-01-22 | 1997-07-22 | C. R. Bard | System for the percutaneous transluminal front-end loading delivery and retrieval of a prosthetic occluder |
US5316262A (en) * | 1992-01-31 | 1994-05-31 | Suprex Corporation | Fluid restrictor apparatus and method for making the same |
US5167363A (en) | 1992-02-10 | 1992-12-01 | Adkinson Steven S | Collapsible storage pen |
US5411481A (en) * | 1992-04-08 | 1995-05-02 | American Cyanamid Co. | Surgical purse string suturing instrument and method |
US5236440A (en) | 1992-04-14 | 1993-08-17 | American Cyanamid Company | Surgical fastener |
US5540712A (en) | 1992-05-01 | 1996-07-30 | Nitinol Medical Technologies, Inc. | Stent and method and apparatus for forming and delivering the same |
US5354308A (en) | 1992-05-01 | 1994-10-11 | Beth Israel Hospital Association | Metal wire stent |
DE4215449C1 (en) * | 1992-05-11 | 1993-09-02 | Ethicon Gmbh & Co Kg, 2000 Norderstedt, De | |
US5312341A (en) * | 1992-08-14 | 1994-05-17 | Wayne State University | Retaining apparatus and procedure for transseptal catheterization |
US6090072A (en) | 1992-10-15 | 2000-07-18 | Scimed Life Systems, Inc. | Expandable introducer sheath |
US5304184A (en) * | 1992-10-19 | 1994-04-19 | Indiana University Foundation | Apparatus and method for positive closure of an internal tissue membrane opening |
US5275826A (en) | 1992-11-13 | 1994-01-04 | Purdue Research Foundation | Fluidized intestinal submucosa and its use as an injectable tissue graft |
US5417699A (en) * | 1992-12-10 | 1995-05-23 | Perclose Incorporated | Device and method for the percutaneous suturing of a vascular puncture site |
US5284488A (en) | 1992-12-23 | 1994-02-08 | Sideris Eleftherios B | Adjustable devices for the occlusion of cardiac defects |
US5320611A (en) | 1993-02-04 | 1994-06-14 | Peter M. Bonutti | Expandable cannula having longitudinal wire and method of use |
US6346074B1 (en) * | 1993-02-22 | 2002-02-12 | Heartport, Inc. | Devices for less invasive intracardiac interventions |
US5797960A (en) | 1993-02-22 | 1998-08-25 | Stevens; John H. | Method and apparatus for thoracoscopic intracardiac procedures |
US5312435A (en) * | 1993-05-17 | 1994-05-17 | Kensey Nash Corporation | Fail predictable, reinforced anchor for hemostatic puncture closure |
US5350363A (en) | 1993-06-14 | 1994-09-27 | Cordis Corporation | Enhanced sheath valve |
DE4324218A1 (en) | 1993-07-19 | 1995-01-26 | Bavaria Med Tech | Cuff catheter |
US5480424A (en) * | 1993-11-01 | 1996-01-02 | Cox; James L. | Heart valve replacement using flexible tubes |
JP3185906B2 (en) * | 1993-11-26 | 2001-07-11 | ニプロ株式会社 | Prosthesis for atrial septal defect |
US5538510A (en) | 1994-01-31 | 1996-07-23 | Cordis Corporation | Catheter having coextruded tubing |
US6334872B1 (en) * | 1994-02-18 | 2002-01-01 | Organogenesis Inc. | Method for treating diseased or damaged organs |
US5683411A (en) | 1994-04-06 | 1997-11-04 | William Cook Europe A/S | Medical article for implantation into the vascular system of a patient |
US5853420A (en) | 1994-04-21 | 1998-12-29 | B. Braun Celsa | Assembly comprising a blood filter for temporary or definitive use and device for implanting it, corresponding filter and method of implanting such a filter |
DE69534640T2 (en) | 1994-04-29 | 2006-08-10 | Scimed Life Systems, Inc., Maple Grove | Stent with collagen |
US6475232B1 (en) * | 1996-12-10 | 2002-11-05 | Purdue Research Foundation | Stent with reduced thrombogenicity |
US5601571A (en) * | 1994-05-17 | 1997-02-11 | Moss; Gerald | Surgical fastener implantation device |
US5453095A (en) | 1994-06-07 | 1995-09-26 | Cordis Corporation | One piece self-aligning, self-lubricating catheter valve |
US5725552A (en) | 1994-07-08 | 1998-03-10 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
US5433727A (en) | 1994-08-16 | 1995-07-18 | Sideris; Eleftherios B. | Centering buttoned device for the occlusion of large defects for occluding |
DE9413645U1 (en) | 1994-08-24 | 1994-10-27 | Schneidt Bernhard Ing Grad | Device for closing a duct, in particular the ductus arteriosus |
US5577299A (en) | 1994-08-26 | 1996-11-26 | Thompson; Carl W. | Quick-release mechanical knot apparatus |
US5618311A (en) * | 1994-09-28 | 1997-04-08 | Gryskiewicz; Joseph M. | Surgical subcuticular fastener system |
US5879366A (en) | 1996-12-20 | 1999-03-09 | W.L. Gore & Associates, Inc. | Self-expanding defect closure device and method of making and using |
US6171329B1 (en) | 1994-12-19 | 2001-01-09 | Gore Enterprise Holdings, Inc. | Self-expanding defect closure device and method of making and using |
US5702421A (en) | 1995-01-11 | 1997-12-30 | Schneidt; Bernhard | Closure device for closing a vascular opening, such as patent ductus arteriosus |
DE69632392T2 (en) * | 1995-01-27 | 2004-09-16 | Scimed Life Systems, Inc., Maple Grove | Embolisation |
US5480353A (en) | 1995-02-02 | 1996-01-02 | Garza, Jr.; Ponciano | Shaker crank for a harvester |
US5634936A (en) * | 1995-02-06 | 1997-06-03 | Scimed Life Systems, Inc. | Device for closing a septal defect |
US5649959A (en) | 1995-02-10 | 1997-07-22 | Sherwood Medical Company | Assembly for sealing a puncture in a vessel |
US5733337A (en) | 1995-04-07 | 1998-03-31 | Organogenesis, Inc. | Tissue repair fabric |
US5711969A (en) | 1995-04-07 | 1998-01-27 | Purdue Research Foundation | Large area submucosal tissue graft constructs |
US5713864A (en) | 1995-04-11 | 1998-02-03 | Sims Level 1, Inc. | Integral conductive polymer resistance heated tubing |
US5603703A (en) | 1995-04-28 | 1997-02-18 | Medtronic, Inc. | Selectively aspirating stylet |
US6322548B1 (en) | 1995-05-10 | 2001-11-27 | Eclipse Surgical Technologies | Delivery catheter system for heart chamber |
US6132438A (en) | 1995-06-07 | 2000-10-17 | Ep Technologies, Inc. | Devices for installing stasis reducing means in body tissue |
US6190353B1 (en) * | 1995-10-13 | 2001-02-20 | Transvascular, Inc. | Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures |
DE69612507T2 (en) * | 1995-10-30 | 2001-08-09 | Childrens Medical Center | SELF-CENTERING, SHIELD-LIKE DEVICE FOR CLOSING A SEPTAL DEFECT |
US5772641A (en) | 1995-12-12 | 1998-06-30 | Medi-Dyne Inc. | Overlapping welds for catheter constructions |
US5717259A (en) | 1996-01-11 | 1998-02-10 | Schexnayder; J. Rodney | Electromagnetic machine |
DE19604817C2 (en) | 1996-02-09 | 2003-06-12 | Pfm Prod Fuer Die Med Ag | Device for closing defect openings in the human or animal body |
CA2197614C (en) | 1996-02-20 | 2002-07-02 | Charles S. Taylor | Surgical instruments and procedures for stabilizing the beating heart during coronary artery bypass graft surgery |
US5733294A (en) | 1996-02-28 | 1998-03-31 | B. Braun Medical, Inc. | Self expanding cardiovascular occlusion device, method of using and method of making the same |
US5853422A (en) | 1996-03-22 | 1998-12-29 | Scimed Life Systems, Inc. | Apparatus and method for closing a septal defect |
US5755791A (en) | 1996-04-05 | 1998-05-26 | Purdue Research Foundation | Perforated submucosal tissue graft constructs |
AR001590A1 (en) | 1996-04-10 | 1997-11-26 | Jorge Alberto Baccaro | Abnormal vascular communications occluder device and applicator cartridge of said device |
AU3186897A (en) | 1996-05-08 | 1997-11-26 | Salviac Limited | An occluder device |
US6488706B1 (en) | 1996-05-08 | 2002-12-03 | Carag Ag | Device for plugging an opening such as in a wall of a hollow or tubular organ |
US6143037A (en) | 1996-06-12 | 2000-11-07 | The Regents Of The University Of Michigan | Compositions and methods for coating medical devices |
US5893856A (en) | 1996-06-12 | 1999-04-13 | Mitek Surgical Products, Inc. | Apparatus and method for binding a first layer of material to a second layer of material |
US5690674A (en) | 1996-07-02 | 1997-11-25 | Cordis Corporation | Wound closure with plug |
US5800516A (en) | 1996-08-08 | 1998-09-01 | Cordis Corporation | Deployable and retrievable shape memory stent/tube and method |
WO1998007375A1 (en) | 1996-08-22 | 1998-02-26 | The Trustees Of Columbia University | Endovascular flexible stapling device |
US5776183A (en) | 1996-08-23 | 1998-07-07 | Kanesaka; Nozomu | Expandable stent |
US5741297A (en) | 1996-08-28 | 1998-04-21 | Simon; Morris | Daisy occluder and method for septal defect repair |
US5810884A (en) | 1996-09-09 | 1998-09-22 | Beth Israel Deaconess Medical Center | Apparatus and method for closing a vascular perforation after percutaneous puncture of a blood vessel in a living subject |
US5861003A (en) | 1996-10-23 | 1999-01-19 | The Cleveland Clinic Foundation | Apparatus and method for occluding a defect or aperture within body surface |
US5944691A (en) | 1996-11-04 | 1999-08-31 | Cordis Corporation | Catheter having an expandable shaft |
JP4676580B2 (en) | 1996-11-05 | 2011-04-27 | パーデュー・リサーチ・ファウンデーション | Myocardial graft composition |
US6315791B1 (en) | 1996-12-03 | 2001-11-13 | Atrium Medical Corporation | Self-expanding prothesis |
WO1998025549A1 (en) | 1996-12-10 | 1998-06-18 | Purdue Research Foundation | Artificial vascular valves |
AU743779B2 (en) * | 1996-12-10 | 2002-02-07 | Cook Biotech, Inc. | Tubular grafts from purified submucosa |
US5776162A (en) | 1997-01-03 | 1998-07-07 | Nitinol Medical Technologies, Inc. | Vessel implantable shape memory appliance with superelastic hinged joint |
JP3134288B2 (en) | 1997-01-30 | 2001-02-13 | 株式会社ニッショー | Endocardial suture surgery tool |
JP3134287B2 (en) | 1997-01-30 | 2001-02-13 | 株式会社ニッショー | Catheter assembly for endocardial suture surgery |
US5993844A (en) | 1997-05-08 | 1999-11-30 | Organogenesis, Inc. | Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix |
US6867248B1 (en) * | 1997-05-12 | 2005-03-15 | Metabolix, Inc. | Polyhydroxyalkanoate compositions having controlled degradation rates |
PT981381E (en) | 1997-05-12 | 2007-04-30 | Metabolix Inc | Polyhydroxyalkanoates for in vivo applications |
US6610764B1 (en) | 1997-05-12 | 2003-08-26 | Metabolix, Inc. | Polyhydroxyalkanoate compositions having controlled degradation rates |
US6071292A (en) | 1997-06-28 | 2000-06-06 | Transvascular, Inc. | Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures |
US6030007A (en) | 1997-07-07 | 2000-02-29 | Hughes Electronics Corporation | Continually adjustable nonreturn knot |
US5928260A (en) * | 1997-07-10 | 1999-07-27 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
DE69840594D1 (en) | 1997-07-22 | 2009-04-09 | Metabolix Inc | POLYHYDROXYALKANOATE MOLDING |
US6828357B1 (en) | 1997-07-31 | 2004-12-07 | Metabolix, Inc. | Polyhydroxyalkanoate compositions having controlled degradation rates |
US6174330B1 (en) * | 1997-08-01 | 2001-01-16 | Schneider (Usa) Inc | Bioabsorbable marker having radiopaque constituents |
US6077880A (en) | 1997-08-08 | 2000-06-20 | Cordis Corporation | Highly radiopaque polyolefins and method for making the same |
US6174322B1 (en) * | 1997-08-08 | 2001-01-16 | Cardia, Inc. | Occlusion device for the closure of a physical anomaly such as a vascular aperture or an aperture in a septum |
US5902287A (en) | 1997-08-20 | 1999-05-11 | Medtronic, Inc. | Guiding catheter and method of making same |
ATE323152T1 (en) * | 1997-09-19 | 2006-04-15 | Metabolix Inc | BIOLOGICAL SYSTEMS FOR THE PRODUCTION OF POLYHYDROXYALKANOATE POLYMERS THAT CONTAIN 4-HYDROXY ACID |
US5902319A (en) | 1997-09-25 | 1999-05-11 | Daley; Robert J. | Bioabsorbable staples |
US6042606A (en) | 1997-09-29 | 2000-03-28 | Cook Incorporated | Radially expandable non-axially contracting surgical stent |
US6106913A (en) | 1997-10-10 | 2000-08-22 | Quantum Group, Inc | Fibrous structures containing nanofibrils and other textile fibers |
US5989268A (en) | 1997-10-28 | 1999-11-23 | Boston Scientific Corporation | Endoscopic hemostatic clipping device |
GB9725390D0 (en) | 1997-12-02 | 1998-01-28 | Smiths Industries Plc | Catheter assemblies and inner cannulae |
US6027519A (en) | 1997-12-15 | 2000-02-22 | Stanford; Ulf Harry | Catheter with expandable multiband segment |
US5976174A (en) | 1997-12-15 | 1999-11-02 | Ruiz; Carlos E. | Medical hole closure device and methods of use |
US5944738A (en) | 1998-02-06 | 1999-08-31 | Aga Medical Corporation | Percutaneous catheter directed constricting occlusion device |
JP3799810B2 (en) * | 1998-03-30 | 2006-07-19 | ニプロ株式会社 | Transcatheter surgery closure plug and catheter assembly |
US6190357B1 (en) | 1998-04-21 | 2001-02-20 | Cardiothoracic Systems, Inc. | Expandable cannula for performing cardiopulmonary bypass and method for using same |
US5993475A (en) | 1998-04-22 | 1999-11-30 | Bristol-Myers Squibb Co. | Tissue repair device |
US6113609A (en) * | 1998-05-26 | 2000-09-05 | Scimed Life Systems, Inc. | Implantable tissue fastener and system for treating gastroesophageal reflux disease |
US7452371B2 (en) | 1999-06-02 | 2008-11-18 | Cook Incorporated | Implantable vascular device |
US6265333B1 (en) | 1998-06-02 | 2001-07-24 | Board Of Regents, University Of Nebraska-Lincoln | Delamination resistant composites prepared by small diameter fiber reinforcement at ply interfaces |
US6740101B2 (en) * | 1998-06-10 | 2004-05-25 | Converge Medical, Inc. | Sutureless anastomosis systems |
US6328822B1 (en) | 1998-06-26 | 2001-12-11 | Kiyohito Ishida | Functionally graded alloy, use thereof and method for producing same |
US6165183A (en) | 1998-07-15 | 2000-12-26 | St. Jude Medical, Inc. | Mitral and tricuspid valve repair |
US6478773B1 (en) * | 1998-12-21 | 2002-11-12 | Micrus Corporation | Apparatus for deployment of micro-coil using a catheter |
US5919200A (en) | 1998-10-09 | 1999-07-06 | Hearten Medical, Inc. | Balloon catheter for abrading a patent foramen ovale and method of using the balloon catheter |
US6183496B1 (en) | 1998-11-02 | 2001-02-06 | Datascope Investment Corp. | Collapsible hemostatic plug |
US7044134B2 (en) | 1999-11-08 | 2006-05-16 | Ev3 Sunnyvale, Inc | Method of implanting a device in the left atrial appendage |
US6152144A (en) | 1998-11-06 | 2000-11-28 | Appriva Medical, Inc. | Method and device for left atrial appendage occlusion |
US7713282B2 (en) * | 1998-11-06 | 2010-05-11 | Atritech, Inc. | Detachable atrial appendage occlusion balloon |
JP3906475B2 (en) * | 1998-12-22 | 2007-04-18 | ニプロ株式会社 | Transcatheter surgery closure plug and catheter assembly |
US6280447B1 (en) | 1998-12-23 | 2001-08-28 | Nuvasive, Inc. | Bony tissue resector |
US6356782B1 (en) * | 1998-12-24 | 2002-03-12 | Vivant Medical, Inc. | Subcutaneous cavity marking device and method |
US6371904B1 (en) * | 1998-12-24 | 2002-04-16 | Vivant Medical, Inc. | Subcutaneous cavity marking device and method |
US6217590B1 (en) * | 1999-01-22 | 2001-04-17 | Scion International, Inc. | Surgical instrument for applying multiple staples and cutting blood vessels and organic structures and method therefor |
US6228097B1 (en) | 1999-01-22 | 2001-05-08 | Scion International, Inc. | Surgical instrument for clipping and cutting blood vessels and organic structures |
CA2363262C (en) * | 1999-03-04 | 2010-09-28 | Tepha, Inc. | Bioabsorbable, biocompatible polymers for tissue engineering |
US6632236B2 (en) | 1999-03-12 | 2003-10-14 | Arteria Medical Science, Inc. | Catheter having radially expandable main body |
WO2000056376A1 (en) * | 1999-03-25 | 2000-09-28 | Metabolix, Inc. | Medical devices and applications of polyhydroxyalkanoate polymers |
ATE305324T1 (en) * | 1999-03-29 | 2005-10-15 | William Cook Europe As | A GUIDE WIRE |
US6277138B1 (en) * | 1999-08-17 | 2001-08-21 | Scion Cardio-Vascular, Inc. | Filter for embolic material mounted on expandable frame |
US6277139B1 (en) | 1999-04-01 | 2001-08-21 | Scion Cardio-Vascular, Inc. | Vascular protection and embolic material retriever |
US6379342B1 (en) * | 1999-04-02 | 2002-04-30 | Scion International, Inc. | Ampoule for dispensing medication and method of use |
US6752813B2 (en) * | 1999-04-09 | 2004-06-22 | Evalve, Inc. | Methods and devices for capturing and fixing leaflets in valve repair |
JP2000300571A (en) * | 1999-04-19 | 2000-10-31 | Nissho Corp | Closure plug for transcatheter operation |
US6206907B1 (en) * | 1999-05-07 | 2001-03-27 | Cardia, Inc. | Occlusion device with stranded wire support arms |
US6712836B1 (en) * | 1999-05-13 | 2004-03-30 | St. Jude Medical Atg, Inc. | Apparatus and methods for closing septal defects and occluding blood flow |
US6379368B1 (en) * | 1999-05-13 | 2002-04-30 | Cardia, Inc. | Occlusion device with non-thrombogenic properties |
US6426145B1 (en) | 1999-05-20 | 2002-07-30 | Scimed Life Systems, Inc. | Radiopaque compositions for visualization of medical devices |
US6488689B1 (en) | 1999-05-20 | 2002-12-03 | Aaron V. Kaplan | Methods and apparatus for transpericardial left atrial appendage closure |
US6165204A (en) | 1999-06-11 | 2000-12-26 | Scion International, Inc. | Shaped suture clip, appliance and method therefor |
US6494888B1 (en) | 1999-06-22 | 2002-12-17 | Ndo Surgical, Inc. | Tissue reconfiguration |
US6306424B1 (en) | 1999-06-30 | 2001-10-23 | Ethicon, Inc. | Foam composite for the repair or regeneration of tissue |
US6398796B2 (en) | 1999-07-13 | 2002-06-04 | Scion Cardio-Vascular, Inc. | Suture with toggle and delivery system |
US6206895B1 (en) | 1999-07-13 | 2001-03-27 | Scion Cardio-Vascular, Inc. | Suture with toggle and delivery system |
US6245080B1 (en) * | 1999-07-13 | 2001-06-12 | Scion Cardio-Vascular, Inc. | Suture with toggle and delivery system |
US7892246B2 (en) * | 1999-07-28 | 2011-02-22 | Bioconnect Systems, Inc. | Devices and methods for interconnecting conduits and closing openings in tissue |
US6328689B1 (en) | 2000-03-23 | 2001-12-11 | Spiration, Inc., | Lung constriction apparatus and method |
US6358238B1 (en) | 1999-09-02 | 2002-03-19 | Scimed Life Systems, Inc. | Expandable micro-catheter |
US6231561B1 (en) | 1999-09-20 | 2001-05-15 | Appriva Medical, Inc. | Method and apparatus for closing a body lumen |
US6551303B1 (en) | 1999-10-27 | 2003-04-22 | Atritech, Inc. | Barrier device for ostium of left atrial appendage |
US6387104B1 (en) * | 1999-11-12 | 2002-05-14 | Scimed Life Systems, Inc. | Method and apparatus for endoscopic repair of the lower esophageal sphincter |
US6371971B1 (en) | 1999-11-15 | 2002-04-16 | Scimed Life Systems, Inc. | Guidewire filter and methods of use |
US7335426B2 (en) | 1999-11-19 | 2008-02-26 | Advanced Bio Prosthetic Surfaces, Ltd. | High strength vacuum deposited nitinol alloy films and method of making same |
US20010041914A1 (en) | 1999-11-22 | 2001-11-15 | Frazier Andrew G.C. | Tissue patch deployment catheter |
US6790218B2 (en) | 1999-12-23 | 2004-09-14 | Swaminathan Jayaraman | Occlusive coil manufacture and delivery |
DE10000137A1 (en) | 2000-01-04 | 2001-07-12 | Pfm Prod Fuer Die Med Ag | Implantate for closing defect apertures in human or animal bodies, bearing structure of which can be reversed from secondary to primary form by elastic force |
US6780197B2 (en) * | 2000-01-05 | 2004-08-24 | Integrated Vascular Systems, Inc. | Apparatus and methods for delivering a vascular closure device to a body lumen |
US20010034567A1 (en) | 2000-01-20 | 2001-10-25 | Allen Marc L. | Remote management of retail petroleum equipment |
FR2804567B1 (en) | 2000-01-31 | 2002-04-12 | St Microelectronics Sa | VIDEO PREAMPLIFIER |
US6227139B1 (en) * | 2000-03-16 | 2001-05-08 | The United States Of America As Represented By The Secretary Of The Navy | Control tab assisted lift reducing system for underwater hydrofoil surface |
US7056294B2 (en) | 2000-04-13 | 2006-06-06 | Ev3 Sunnyvale, Inc | Method and apparatus for accessing the left atrial appendage |
JP3844661B2 (en) * | 2000-04-19 | 2006-11-15 | ラディ・メディカル・システムズ・アクチェボラーグ | Intra-arterial embolus |
US6551344B2 (en) * | 2000-04-26 | 2003-04-22 | Ev3 Inc. | Septal defect occluder |
US6214029B1 (en) * | 2000-04-26 | 2001-04-10 | Microvena Corporation | Septal defect occluder |
US6352552B1 (en) * | 2000-05-02 | 2002-03-05 | Scion Cardio-Vascular, Inc. | Stent |
US6599448B1 (en) | 2000-05-10 | 2003-07-29 | Hydromer, Inc. | Radio-opaque polymeric compositions |
US6334864B1 (en) | 2000-05-17 | 2002-01-01 | Aga Medical Corp. | Alignment member for delivering a non-symmetric device with a predefined orientation |
US6494846B1 (en) | 2000-06-20 | 2002-12-17 | Wayne Margolis Family Partnership, Ltd. | Dual-mode catheter |
US20020164729A1 (en) | 2000-07-21 | 2002-11-07 | Skraly Frank A. | Production of polyhydroxyalkanoates from polyols |
US6440152B1 (en) | 2000-07-28 | 2002-08-27 | Microvena Corporation | Defect occluder release assembly and method |
US6867249B2 (en) * | 2000-08-18 | 2005-03-15 | Kin Man Amazon Lee | Lightweight and porous construction materials containing rubber |
JP2004506469A (en) | 2000-08-18 | 2004-03-04 | アトリテック, インコーポレイテッド | Expandable implantable device for filtering blood flow from the atrial appendage |
EP1320329A4 (en) | 2000-09-01 | 2004-09-22 | Advanced Vasular Technologies | Endovascular fastener and grafting apparatus and method |
US6364853B1 (en) * | 2000-09-11 | 2002-04-02 | Scion International, Inc. | Irrigation and suction valve and method therefor |
WO2002024106A2 (en) * | 2000-09-21 | 2002-03-28 | Atritech, Inc. | Apparatus for implanting devices in atrial appendages |
JP3722682B2 (en) * | 2000-09-21 | 2005-11-30 | 富士通株式会社 | Transmission device that automatically changes the type of transmission data within a specific band |
US20020072792A1 (en) * | 2000-09-22 | 2002-06-13 | Robert Burgermeister | Stent with optimal strength and radiopacity characteristics |
JP2004508884A (en) * | 2000-09-25 | 2004-03-25 | コヒージョン テクノロジーズ, インコーポレイテッド | Resorbable anastomotic stent and plug |
US6666861B1 (en) | 2000-10-05 | 2003-12-23 | James R. Grabek | Atrial appendage remodeling device and method |
US6375625B1 (en) * | 2000-10-18 | 2002-04-23 | Scion Valley, Inc. | In-line specimen trap and method therefor |
US6629901B2 (en) | 2000-11-09 | 2003-10-07 | Ben Huang | Composite grip for golf clubs |
US6508828B1 (en) * | 2000-11-03 | 2003-01-21 | Radi Medical Systems Ab | Sealing device and wound closure device |
US6746404B2 (en) | 2000-12-18 | 2004-06-08 | Biosense, Inc. | Method for anchoring a medical device between tissue |
US6585719B2 (en) | 2001-01-04 | 2003-07-01 | Scimed Life Systems, Inc. | Low profile metal/polymer tubes |
US20020128680A1 (en) | 2001-01-25 | 2002-09-12 | Pavlovic Jennifer L. | Distal protection device with electrospun polymer fiber matrix |
US6550480B2 (en) | 2001-01-31 | 2003-04-22 | Numed/Tech Llc | Lumen occluders made from thermodynamic materials |
US6450987B1 (en) | 2001-02-01 | 2002-09-17 | Innercool Therapies, Inc. | Collapsible guidewire lumen |
JP4097924B2 (en) * | 2001-02-05 | 2008-06-11 | オリンパス株式会社 | Biological tissue clip device |
US20020107531A1 (en) | 2001-02-06 | 2002-08-08 | Schreck Stefan G. | Method and system for tissue repair using dual catheters |
US6623518B2 (en) | 2001-02-26 | 2003-09-23 | Ev3 Peripheral, Inc. | Implant delivery system with interlock |
CA2441119A1 (en) * | 2001-03-08 | 2002-09-19 | Atritech, Inc. | Atrial filter implants |
DE60226719D1 (en) * | 2001-04-02 | 2008-07-03 | Bladder Man Systems Llc | ADJUSTABLE BALLOON FREE CATHEDRAL |
US6726696B1 (en) * | 2001-04-24 | 2004-04-27 | Advanced Catheter Engineering, Inc. | Patches and collars for medical applications and methods of use |
WO2002089863A1 (en) * | 2001-05-04 | 2002-11-14 | Concentric Medical | Bioactive polymer vaso-occlusive device |
US6921410B2 (en) | 2001-05-29 | 2005-07-26 | Scimed Life Systems, Inc. | Injection molded vaso-occlusive elements |
US6537300B2 (en) | 2001-05-30 | 2003-03-25 | Scimed Life Systems, Inc. | Implantable obstruction device for septal defects |
US7338514B2 (en) | 2001-06-01 | 2008-03-04 | St. Jude Medical, Cardiology Division, Inc. | Closure devices, related delivery methods and tools, and related methods of use |
CA2449468A1 (en) | 2001-06-04 | 2002-12-12 | Albert Einstein Healthcare Network | Cardiac stimulating apparatus having a blood clot filter and atrial pacer |
US6585755B2 (en) | 2001-06-29 | 2003-07-01 | Advanced Cardiovascular | Polymeric stent suitable for imaging by MRI and fluoroscopy |
US20030023266A1 (en) * | 2001-07-19 | 2003-01-30 | Borillo Thomas E. | Individually customized atrial appendage implant device |
US7288105B2 (en) * | 2001-08-01 | 2007-10-30 | Ev3 Endovascular, Inc. | Tissue opening occluder |
US6776784B2 (en) * | 2001-09-06 | 2004-08-17 | Core Medical, Inc. | Clip apparatus for closing septal defects and methods of use |
US6702835B2 (en) | 2001-09-07 | 2004-03-09 | Core Medical, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
US6596013B2 (en) * | 2001-09-20 | 2003-07-22 | Scimed Life Systems, Inc. | Method and apparatus for treating septal defects |
US7094245B2 (en) * | 2001-10-05 | 2006-08-22 | Scimed Life Systems, Inc. | Device and method for through the scope endoscopic hemostatic clipping |
US7318833B2 (en) | 2001-12-19 | 2008-01-15 | Nmt Medical, Inc. | PFO closure device with flexible thrombogenic joint and improved dislodgement resistance |
EP1467661A4 (en) | 2001-12-19 | 2008-11-05 | Nmt Medical Inc | Septal occluder and associated methods |
US20030139819A1 (en) * | 2002-01-18 | 2003-07-24 | Beer Nicholas De | Method and apparatus for closing septal defects |
JP2005528181A (en) * | 2002-06-05 | 2005-09-22 | エヌエムティー メディカル インコーポレイテッド | Patent foramen ovale (PFO) occlusion device with radial and circumferential supports |
WO2004037333A1 (en) | 2002-10-25 | 2004-05-06 | Nmt Medical, Inc. | Expandable sheath tubing |
CA2503349A1 (en) | 2002-11-06 | 2004-05-27 | Nmt Medical, Inc. | Medical devices utilizing modified shape memory alloy |
CA2503666A1 (en) | 2002-12-09 | 2004-06-24 | Nmt Medical, Inc. | Septal closure devices |
US20040234567A1 (en) | 2003-05-22 | 2004-11-25 | Dawson Richard A. | Collapsible shield for smoking animal lure |
WO2005007195A1 (en) | 2003-07-08 | 2005-01-27 | Tepha, Inc. | Poly-4-hydroxybutyrate matrices for sustained drug delivery |
EP1651116B1 (en) * | 2003-07-14 | 2013-06-26 | W.L. Gore & Associates, Inc. | Tubular patent foramen ovale (pfo) closure device with catch system |
US8480706B2 (en) * | 2003-07-14 | 2013-07-09 | W.L. Gore & Associates, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
WO2005055834A1 (en) | 2003-11-20 | 2005-06-23 | Nmt Medical, Inc. | Device, with electrospun fabric, for a percutaneous transluminal procedure, and methods thereof |
WO2005074813A1 (en) | 2004-02-04 | 2005-08-18 | Carag Ag | An implant for occluding a body passage |
US7871419B2 (en) * | 2004-03-03 | 2011-01-18 | Nmt Medical, Inc. | Delivery/recovery system for septal occluder |
US7704268B2 (en) | 2004-05-07 | 2010-04-27 | Nmt Medical, Inc. | Closure device with hinges |
US8257389B2 (en) * | 2004-05-07 | 2012-09-04 | W.L. Gore & Associates, Inc. | Catching mechanisms for tubular septal occluder |
US7842069B2 (en) * | 2004-05-07 | 2010-11-30 | Nmt Medical, Inc. | Inflatable occluder |
US7918872B2 (en) * | 2004-07-30 | 2011-04-05 | Codman & Shurtleff, Inc. | Embolic device delivery system with retractable partially coiled-fiber release |
EP1827247B8 (en) * | 2004-09-24 | 2020-05-06 | W.L. Gore & Associates, Inc. | Occluder device double securement system for delivery/recovery of such occluder device |
US8277480B2 (en) | 2005-03-18 | 2012-10-02 | W.L. Gore & Associates, Inc. | Catch member for PFO occluder |
AU2006235506B2 (en) | 2005-04-11 | 2011-06-30 | Terumo Kabushiki Kaisha | Methods and apparatus to achieve a closure of a layered tissue defect |
EP1962695A1 (en) | 2005-12-22 | 2008-09-03 | NMT Medical, Inc. | Catch members for occluder devices |
US8062325B2 (en) * | 2006-07-31 | 2011-11-22 | Codman & Shurtleff, Inc. | Implantable medical device detachment system and methods of using the same |
-
2007
- 2007-03-28 US US11/729,045 patent/US8551135B2/en active Active
- 2007-03-29 ES ES07759723.5T patent/ES2588687T3/en active Active
- 2007-03-29 EP EP07759723.5A patent/EP2001368B1/en active Active
- 2007-03-29 WO PCT/US2007/065532 patent/WO2007115114A1/en active Application Filing
-
2013
- 2013-09-13 US US14/026,896 patent/US20140018848A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9916825B2 (en) | 2015-09-29 | 2018-03-13 | Yandex Europe Ag | Method and system for text-to-speech synthesis |
Also Published As
Publication number | Publication date |
---|---|
EP2001368B1 (en) | 2016-07-20 |
EP2001368A1 (en) | 2008-12-17 |
US20070276415A1 (en) | 2007-11-29 |
WO2007115114A1 (en) | 2007-10-11 |
US8551135B2 (en) | 2013-10-08 |
ES2588687T3 (en) | 2016-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8551135B2 (en) | Screw catch mechanism for PFO occluder and method of use | |
US8870913B2 (en) | Catch system with locking cap for patent foramen ovale (PFO) occluder | |
EP2004068B1 (en) | Deformable flap catch mechanism for occluder device | |
US9084603B2 (en) | Catch members for occluder devices | |
US8636765B2 (en) | Catch member for PFO occluder | |
US8764848B2 (en) | Occluder device double securement system for delivery/recovery of such occluder device | |
US8715319B2 (en) | Catch member for septal occluder with adjustable-length center joint | |
US8109946B2 (en) | Adjustable length patent foramen ovale (PFO) occluder and catch system | |
US8992545B2 (en) | Implant-catheter attachment mechanism using snare and method of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |